Clinical & Diagnostic
Surfix Diagnostics alongside the Netherlands Cancer Institute (NKI) and CRCbioscreen, announce a collaboration aimed at enhancing colorectal cancer (CRC) s...
July 10, 2024 | News
Immorna Biotherapeutics, Inc. (Immorna), a clinical stage biotechnology company developing both self-replicating and conventional mRNA-based therapeutics a...
July 09, 2024 | News
Hinova Pharmaceuticals a leading biopharmaceutical company dedicated to developing innovative cancer therapies, today announced that the U.S. Food an...
July 08, 2024 | News
- Following its initial approval for the treatment of relapsed/refractory multiple myeloma (R/R MM), XPOVIO® has now received approval as a monoth...
July 08, 2024 | News
Aptamer Group , the developer of novel Optimer® binders to enable innovation in the life sciences industry, is pleased to announce a new agreem...
July 05, 2024 | News
The APPIS Innovator Program 2024 has concluded with an impressive showcase of 49 entries from 21 countries, each addressing critical barrie...
July 04, 2024 | News
Provides Lilly access to Radionetics’ proprietary GPCR targeting small molecule radiopharmaceuticals Radionetics to receive $140 million upfront p...
July 02, 2024 | News
As experts from around the globe gather at the annual Society for Informatics in Medicine (SIIM) conference, Bayer and Rad AI are announcing a collaboratio...
June 28, 2024 | News
- XPOVIO® is the first XPO1 inhibitor approved for reimbursement by South Korea's National Health Insurance Service (NHIS) for the treat...
June 27, 2024 | News
Developed a 'Niclosamide-based multi-treatment drug' that can simultaneously treat mosquito-borne viral infections such as four serotypes of dengue virus...
June 26, 2024 | News
Thermo Scientific™ KingFisher™ PlasmidPro prepares high purity plasmid DNA in approximately 75 minutes, half the traditional process time and w...
June 26, 2024 | News
U.S. Food and Drug Administration (FDA) approved the IND application for NouvNeu001, a cell therapy product from iRegene therapeutics targeting Parkinson's...
June 25, 2024 | News
— Approval for previously treated metastatic colorectal cancer based on results from positive, global, Phase III FRESCO-2 Trial — — FRUZ...
June 24, 2024 | News
Gilead Sciences, Inc. announced topline results from an interim analysis of its pivotal Phase 3 PURPOSE 1 trial, demonstrating that the company’s twi...
June 21, 2024 | News
Most Read
Bio Jobs
News